Description
Fertility Services Market Analysis
Market Overview
The primary market drivers accelerating market expansion are rising levels of stress, obesity, frequent smoking, and environmental variables. There is a significant need for fertilization services as a result of a number of social and environmental issues, including lifestyle modifications such as anxiety or depression, overweight, and heavy alcohol consumption.
For instance, 4% fewer children were born in the nation in 2020 compared to 2019, as per NPR, a semi media institution in the US. At 55.8 births per 1,000 women aged between 15 to 44, according to preliminary data, the total fertility rate reached yet another record low. When infertility rates rise, there will be a greater need for fertility services.
Segment Overview
Underlying reason, Therapy type, and Regional Insights are the three types of segment insights that make up Global Fertility Services.
Male and female infertility are included in the market segmentation for fertility services based on the underlying cause.
The market data for fertility services has been divided by medication taken into ART and insufficiency medications.
The high percentage is attributed to a rise in the infertile rate, increased awareness of fertility services, technological advancements, and supportive government initiatives.
Regional Analysis
The analysis offers market insights for North America, Europe, Asia-Pacific, and the rest of the world, by region. The market for fertility services in Europe, which had sales of $ 12.6871 billion in 2021, is anticipated to rise at a substantial CAGR throughout the study period. The high percentage is attributed to a rise in the failure rate, increased awareness of fertility services, technological advancements, and supportive government initiatives.
For instance, per the European Society of Reproductive Biology and Embryology, the European Union does have the highest proportion of infertile in the world, affecting almost 25 million people. North America is expected to expand significantly during the projection period.
Major Players
The Global Fertility Service Sector is home to a variety of businesses, including the Irvine Scientific Company Inc., Cook Medical, Vitrolife, Monash IVF Group, Ferring B. V, Kitazato Cooperative, and Care Fertility, among others.
COVID 19 Impacts
The COVID-19 pandemic initially had a negative impact on the market for fertility services, but it quickly rebounded with a boost as many governments encouraged the restoration of infertility clinics, according to The Business Research Company’s estimate of the worldwide fertility services industry.
Since they followed the rules that were logistically feasible in their clinical setup, aligned their protocols with their hospital regulations, and was in agreement with the views of their clinical leaders, many people were seeking intending to go to infertility centres. Future COVID-19 immunisation rates are predicted to improve, which will benefit the market for fertility services because many nations are already in the unlocking stage and couples seeking treatment won’t need to put off their plans.
The rise in same-sex marriages is one of the main factors contributing to the market’s explosive expansion, and it is anticipated that this trend will continue during the projection period. By using Partnership IVF, a type of IVF for lesbian couples that allows both partners to become physically active in the creation of their kid, same-sex couples will have a good impact on the IVF services.
In this procedure, one partner provides the eggs, which are fertilised by sperm donation, and the other partner becomes pregnant. The market for fertility services will therefore grow as a result of the rise in same-sex unions.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 13
1.1.1 MARKET SYNOPSIS 13
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 14
2.2 RESEARCH OBJECTIVE 14
2.3 LIST OF ASSUMPTIONS & LIMITATIONS 14
3 RESEARCH METHODOLOGY
3.1 OVERVIEW 16
3.2 DATA MINING 16
3.3 SECONDARY RESEARCH 17
3.4 PRIMARY RESEARCH 18
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 19
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
3.6.1 BOTTOM-UP APPROACH 22
3.6.2 TOP-DOWN APPROACH 22
3.7 DATA TRIANGULATION 23
3.8 VALIDATION 23
4 MARKET DYNAMICS
4.1 OVERVIEW 24
4.2 DRIVERS 25
4.2.1 GROWTH IN THE MEDIAN AGE OF FIRST-TIME MOTHERHOOD AND DECLINING FERTILITY RATE 25
4.2.2 TECHNOLOGICAL ADVANCEMENTS IN FERTILITY TREATMENT 25
4.2.3 INCREASING PREVALENCE OF OBESITY AND CONSUMPTION OF ALCOHOL/CIGARETTES 25
4.2.4 DRIVERS IMPACT ANALYSIS 26
4.3 RESTRAINTS 26
4.3.1 HIGH PROCEDURAL COSTS OF ASSISTED REPRODUCTIVE TECHNIQUES IN DEVELOPED MARKETS 26
4.3.2 ETHICAL AND SOCIAL CONCERNS 27
4.3.3 RESTRAINTS IMPACT ANALYSIS 27
4.4 OPPORTUNITIES 28
4.4.1 REIMBURSEMENT FOR FERTILITY TREATMENTS 28
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 29
5.1.1 THREAT OF NEW ENTRANTS 29
5.1.2 BARGAINING POWER OF SUPPLIERS 30
5.1.3 THREAT OF SUBSTITUTES 30
5.1.4 BARGAINING POWER OF BUYERS 30
5.1.5 INTENSITY OF RIVALRY 30
5.2 VALUE CHAIN ANALYSIS 31
5.2.1 R&D AND DESIGNING 31
5.2.2 MANUFACTURING 32
5.2.3 DISTRIBUTION 32
5.2.4 MARKETING & SALES 32
5.2.5 POST-SALES MONITORING 32
5.3 COVID-19 IMPACT ANALYSIS 33
5.3.1 IMPACT ON GROWTH RATE 33
5.3.2 IMPACT ON MAJOR PLAYERS 33
5.3.3 IMPACT ON MAJOR REGIONS 33
6 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE
6.1 OVERVIEW 34
6.2 FEMALE INFERTILITY 35
6.3 MALE INFERTILITY 36
7 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE
7.1 OVERVIEW 37
7.2 ASSISTED REPRODUCTIVE TECHNOLOGY (ART) 38
7.2.1 IN-VITRO FERTILIZATION (IVF) 39
7.2.2 FROZEN EMBRYO REPLACEMENT (FER) 39
7.2.3 ARTIFICIAL INSEMINATION 40
7.2.4 OTHERS 40
7.3 INFERTILITY DRUGS 41
8 GLOBAL FERTILITY SERVICES MARKET, BY REGION
8.1 OVERVIEW 42
8.2 EUROPE 43
8.2.1 WESTERN EUROPE 45
8.2.1.1 GERMANY 46
8.2.1.2 UK 47
8.2.1.3 FRANCE 48
8.2.1.4 ITALY 49
8.2.1.5 SPAIN 50
8.2.1.6 REST OF WESTERN EUROPE 51
8.2.2 EASTERN EUROPE 52
8.3 AMERICAS 54
8.3.1 NORTH AMERICA 56
8.3.1.1 US 57
8.3.1.2 CANADA 58
8.3.2 LATIN AMERICA 59
8.4 ASIA-PACIFIC 61
8.4.1 JAPAN 62
8.4.2 CHINA 63
8.4.3 INDIA 64
8.4.4 SOUTH KOREA 65
8.4.5 AUSTRALIA 66
8.4.6 REST OF ASIA PACIFIC 67
8.5 MIDDLE EAST & AFRICA 69
8.5.1 MIDDLE EAST 70
8.5.2 AFRICA 71
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW 73
9.2 MAJOR PLAYERS IN THE GLOBAL FERTILITY SERVICES MARKET 73
9.3 COMPETITIVE BENCHMARKING 74
9.4 COMPETITOR DASHBOARD 75
9.5 DEVELOPMENTS IN THE GLOBAL FERTILITY SERVICES MARKET 76
9.5.1 ACQUISITION 76
9.5.2 COLLABORATION 76
9.5.3 EXPANSION 76
9.5.4 DEVELOPMENT 77
9.5.5 JOINT VENTURE 77
9.5.6 PRODUCT LAUNCH/PRODUCT APPROVAL 77
10 COMPANY PROFILES
10.1 MERCK KGAA 78
10.1.1 COMPANY OVERVIEW 78
10.1.2 FINANCIAL OVERVIEW 79
10.1.3 PRODUCTS/SERVICES OFFERED 79
10.1.4 KEY DEVELOPMENTS 80
10.1.5 SWOT ANALYSIS 80
10.1.6 KEY STRATEGIES 81
10.2 COOPERSURGICAL, INC. 82
10.2.1 COMPANY OVERVIEW 82
10.2.2 FINANCIAL OVERVIEW 83
10.2.3 PRODUCTS/SERVICES OFFERED 83
10.2.4 KEY DEVELOPMENTS 84
10.2.5 SWOT ANALYSIS 85
10.2.6 KEY STRATEGIES 85
10.3 CARE FERTILITY 86
10.3.1 COMPANY OVERVIEW 86
10.3.2 FINANCIAL OVERVIEW 86
10.3.3 PRODUCTS/SERVICES OFFERED 86
10.3.4 KEY DEVELOPMENTS 87
10.3.5 SWOT ANALYSIS 87
10.3.6 KEY STRATEGIES 87
10.4 FERRING BV. 88
10.4.1 COMPANY OVERVIEW 88
10.4.2 FINANCIAL OVERVIEW 88
10.4.3 PRODUCTS/SERVICES OFFERED 88
10.4.4 KEY DEVELOPMENTS 89
10.4.5 SWOT ANALYSIS 89
10.4.6 KEY STRATEGIES 89
10.5 INVO BIOSCIENCE 90
10.5.1 COMPANY OVERVIEW 90
10.5.2 FINANCIAL OVERVIEW 90
10.5.3 PRODUCTS/SERVICES OFFERED 90
10.5.4 KEY DEVELOPMENTS 91
10.5.5 SWOT ANALYSIS 91
10.5.6 KEY STRATEGIES 91
10.6 VITROLIFE 92
10.6.1 COMPANY OVERVIEW 92
10.6.2 FINANCIAL OVERVIEW 92
10.6.3 PRODUCTS/SERVICES OFFERED 93
10.6.4 KEY DEVELOPMENTS 94
10.6.5 SWOT ANALYSIS 95
10.6.6 KEY STRATEGIES 95
10.7 MONASH IVF GROUP 96
10.7.1 COMPANY OVERVIEW 96
10.7.2 FINANCIAL OVERVIEW 96
10.7.3 PRODUCTS/SERVICES OFFERED 97
10.7.4 KEY DEVELOPMENTS 97
10.7.5 SWOT ANALYSIS 98
10.7.6 KEY STRATEGIES 98
10.8 COOK 99
10.8.1 COMPANY OVERVIEW 99
10.8.2 FINANCIAL OVERVIEW 99
10.8.3 PRODUCTS/SERVICES OFFERED 99
10.8.4 KEY DEVELOPMENTS 100
10.8.5 SWOT ANALYSIS 101
10.8.6 KEY STRATEGIES 101
10.9 FUJIFILM IRVINE SCIENTIFIC 102
10.9.1 COMPANY OVERVIEW 102
10.9.2 FINANCIAL OVERVIEW 102
10.9.3 PRODUCTS/SERVICES OFFERED 103
10.9.4 KEY DEVELOPMENTS 103
10.9.5 SWOT ANALYSIS 104
10.9.6 KEY STRATEGIES 104
10.10 KITAZATO CORPORATION 105
10.10.1 COMPANY OVERVIEW 105
10.10.2 FINANCIAL OVERVIEW 105
10.10.3 PRODUCTS/SERVICES OFFERED 105
10.10.4 KEY DEVELOPMENTS 106
10.10.5 SWOT ANALYSIS 106
10.10.6 KEY STRATEGIES 106
11 APPENDIX
11.1 REFERENCES 107
11.2 RELATED REPORTS 107
